Extended-Interval Dosing of an Immune Checkpoint Inhibitor Following a Complete Response in Melanoma: A Case Report

J Dermatol. 2025 Oct;52(10):e942-e943. doi: 10.1111/1346-8138.17899. Epub 2025 Aug 20.

Authors

Yoshiyuki Matsui¹, Junji Kato¹, Tokimasa Hida¹, Kohei Horimoto¹, Sayuri Sato¹, Hisashi Uhara¹

Affiliation

¹ Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.

PMID: 40833205
DOI: 10.1111/1346-8138.17899

No abstract available

Publication types

Letter